Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 13601 - 13625 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol FlyGlycoDB Evidence ▲ References
DOID:3627 aortic aneurysm RGD:62058 Rattus norvegicus (Norway rat) 29473 Aoc3 mutant phenotype evidence used in manual assertion
  • PMID:16397885
DOID:384 Wolff-Parkinson-White syndrome HGNC:9386 Homo sapiens (human) 51422 PRKAG2 mutant phenotype evidence used in manual assertion
  • PMID:15611370
DOID:9261 nasopharynx carcinoma HGNC:25941 Homo sapiens (human) 54790 TET2 mutant phenotype evidence used in manual assertion
  • PMID:32774157
DOID:1289 neurodegenerative disease WB:WBGene00003168 Caenorhabditis elegans 181728 mec-4 mutant phenotype evidence used in manual assertion
  • PMID:8107806
DOID:1793 pancreatic cancer RGD:3849 Rattus norvegicus (Norway rat) 24827 Tgfa mutant phenotype evidence used in manual assertion
  • PMID:17785207
DOID:2741 bilirubin metabolic disorder RGD:69300 Rattus norvegicus (Norway rat) 58978 Slco1b2 mutant phenotype evidence used in manual assertion
  • PMID:32528832
DOID:3525 middle cerebral artery infarction HGNC:3415 Homo sapiens (human) 2056 EPO mutant phenotype evidence used in manual assertion
  • PMID:20547143
DOID:1520 colon carcinoma HGNC:3227 Homo sapiens (human) 1948 EFNB2 mutant phenotype evidence used in manual assertion
  • PMID:15083195
DOID:2921 glomerulonephritis RGD:3283 Rattus norvegicus (Norway rat) 24628 Pdgfb mutant phenotype evidence used in manual assertion
  • PMID:11316849
DOID:9975 cocaine dependence RGD:621531 Rattus norvegicus (Norway rat) 50592 Gria1 mutant phenotype evidence used in manual assertion
  • PMID:18430032
  • PMID:21613507
DOID:3070 high grade glioma HGNC:3415 Homo sapiens (human) 2056 EPO mutant phenotype evidence used in manual assertion
  • PMID:21749867
DOID:114 heart disease RGD:70982 Rattus norvegicus (Norway rat) 84027 Gsk3b mutant phenotype evidence used in manual assertion
  • PMID:28440874
DOID:9256 colorectal cancer HGNC:28859 Homo sapiens (human) 29923 HILPDA mutant phenotype evidence used in manual assertion
  • PMID:23916472
DOID:11984 hypertrophic cardiomyopathy HGNC:2537 Homo sapiens (human) 1514 CTSL mutant phenotype evidence used in manual assertion
  • PMID:19096818
DOID:3910 lung adenocarcinoma HGNC:9346 Homo sapiens (human) 639 PRDM1 mutant phenotype evidence used in manual assertion
  • PMID:28378641
DOID:1679 cystitis RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf mutant phenotype evidence used in manual assertion
  • PMID:19996110
DOID:1679 cystitis RGD:3811 Rattus norvegicus (Norway rat) 24807 Tacr1 mutant phenotype evidence used in manual assertion
  • PMID:17382773
DOID:2841 asthma RGD:3435 Rattus norvegicus (Norway rat) 24929 Ptger3 mutant phenotype evidence used in manual assertion
  • PMID:23221044
DOID:11832 visual epilepsy RGD:2735 Rattus norvegicus (Norway rat) 24407 Grik5 mutant phenotype evidence used in manual assertion
  • PMID:12080343
DOID:1588 thrombocytopenia RGD:3825 Rattus norvegicus (Norway rat) 24816 Tbxa2r mutant phenotype evidence used in manual assertion
  • PMID:2528013
DOID:6432 pulmonary hypertension RGD:2536 Rattus norvegicus (Norway rat) 50672 Ednrb mutant phenotype evidence used in manual assertion
  • PMID:18091567
DOID:0080855 Parkinsonism RGD:3684 Rattus norvegicus (Norway rat) 25715 Slc11a2 mutant phenotype evidence used in manual assertion
  • PMID:19011085
DOID:707 B-cell lymphoma HGNC:1133 Homo sapiens (human) 695 BTK mutant phenotype evidence used in manual assertion
  • PMID:28348046
DOID:8893 psoriasis HGNC:2505 Homo sapiens (human) 1493 CTLA4 mutant phenotype evidence used in manual assertion
  • PMID:10974034
DOID:3526 cerebral infarction HGNC:16369 Homo sapiens (human) 11315 PARK7 mutant phenotype evidence used in manual assertion
  • PMID:18003894
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.4.0

Last updated: December 8, 2025